BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 4086902)

  • 1. [On the results of hydatidiform mole managed by Niigata method].
    Hando T; Kodama S; Takeuchi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2722-30. PubMed ID: 4086902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [On the follow up period of postmolar patient (author's transl)].
    Hando T; Maruyama S; Watanabe S; Hirogami T; Obata N; Kanazawa K; Takeuchi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Mar; 34(3):287-91. PubMed ID: 7069243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on the viability of trophoblast after termination of various kinds of pregnancies (author's transl)].
    Kanda K
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Oct; 32(10):1575-82. PubMed ID: 6263995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The excretion of chorionic gonadetropin in 55 cases of hydatidiform mole (author's transl)].
    Lichtenegger W; Weiss PA
    Geburtshilfe Frauenheilkd; 1977 Apr; 37(4):334-7. PubMed ID: 192629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on follow-up procedure for postmolar patients].
    Endo N; Kobayashi O; Takamizawa H
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Apr; 36(4):531-8. PubMed ID: 6715935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of sulprostone in the evacuation of molar pregnancies].
    Pinet C; Colau JC
    Rev Fr Gynecol Obstet; 1991 Jan; 86(1):53-5. PubMed ID: 2068488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human chorionic gonadotropin and its subunits in hydatidiform mole and choriocarcinoma.
    Dawood MY; Saxena BB; Landesman R
    Obstet Gynecol; 1977 Aug; 50(2):172-81. PubMed ID: 195242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study.
    Kim BW; Cho H; Kim H; Nam EJ; Kim SW; Kim S; Kim YT; Kim JH
    Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):100-5. PubMed ID: 22055909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of the malignant form of trophoblastic disease after a hydatidiform mole: systematic or selective chemotherapy].
    Delvoye P; Robyn C
    J Gynecol Obstet Biol Reprod (Paris); 1975 Mar; 4(2):267-93. PubMed ID: 181422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
    Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
    Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
    Elmer DB; Granai CO; Ball HG; Curry SL
    Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
    Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choriocarcinoma following ovarian hydatidiform mole: a case report.
    Joneborg U; Papadogiannakis N; Lindell G; Marions L
    J Reprod Med; 2011; 56(11-12):511-4. PubMed ID: 22195336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial hydatidiform mole with false-negative urine human chorionic gonadatropin test in the emergency department.
    Mundangepfupfu T; Waseem M
    J Emerg Med; 2014 Mar; 46(3):348-50. PubMed ID: 24188605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY; Yen GL
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of hysteroscopy in diagnosis and management of trophoblastic disease].
    Suzuki A; Kawaguchi K; Konishi I; Ida K; Fujii S; Matsuura S
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Feb; 36(2):255-60. PubMed ID: 6321615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of CA-125 in trophoblastic disease.
    Kohorn EI
    Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On interrupted postmolar choriocarcinoma].
    Hando T; Kodama S; Takeuchi S; Goto S
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Oct; 37(10):2019-22. PubMed ID: 4078405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete hydatidiform mole in women aged 40 to 49 years.
    Elias KM; Shoni M; Bernstein M; Goldstein DP; Berkowitz RS
    J Reprod Med; 2012; 57(5-6):254-8. PubMed ID: 22696822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.